Charles River Laboratories International (CRL) Depreciation & Amortization (CF) (2009 - 2025)

Charles River Laboratories International's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $78.3 million for Q4 2025.

• In Q4 2025, Depreciation & Amortization (CF) fell 23.34% year-over-year to $78.3 million; the TTM figure through Dec 2025 stood at $403.3 million (up 11.49% YoY), while the FY2025 annual figure was $403.3 million, up 11.49% from the prior year.
• Depreciation & Amortization (CF) was $78.3 million for Q4 2025 at Charles River Laboratories International, down from $85.2 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $120.4 million in Q1 2025 to a low of $61.5 million in Q1 2021.
• Historically, Depreciation & Amortization (CF) has averaged $82.4 million across 5 years, with a median of $78.0 million in 2023.
• Biggest YoY gain for Depreciation & Amortization (CF) was 41.01% in 2025; the steepest drop was 23.34% in 2025.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $67.2 million in 2021, then grew by 15.32% to $77.5 million in 2022, then grew by 3.83% to $80.5 million in 2023, then grew by 26.82% to $102.1 million in 2024, then slipped by 23.34% to $78.3 million in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $78.3 million (Q4 2025), $85.2 million (Q3 2025), and $119.5 million (Q2 2025), per Business Quant data.